BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Following peer review, applications are passed to the NIH’s funding institutes and centers, such as the National Institute of Allergy and Infectious Diseases (NIAID) or the National Cancer Institute ...

Africa accounts for only 3% of all medicine production globally, and more than 90% of drugs and 99% of vaccines consumed are imported.1 The continent has not been well positioned to address these gaps ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...

Tran, CEO of BiomedSAN JOSE, CA, UNITED STATES, March 3, 2025 /EINPresswire / -- Biomed Industries, Inc. (Biomed) today announced that it will present the results of its Phase 2/3 clinical trials ...

has received the first shipment of HALO™ Clarity devices to commence its clinical trial evaluating the treatment of mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) in ...

Graduate students are involved in research at both the MA, MS, and PhD level. PhD students start research once they find a thesis advisor. There are four main research groups in the department: ...

Phase 2 trials are underway in two parts. The first, which has been classified as 2A, is the 9.77-kilometre stretch from Dharavi to Acharya Atrey Chowk MMRC said in a press note that system trials for ...

HALO™ Clarity Devices Successfully Shipped for First Phase of Clinical Trials HOUSTON, TX, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or ...